![George Migausky](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
George Migausky
Director/Board Member at
REGENXBIO INC.
Net worth: 5 M $ as of 2026-09-29
Profile
Mr. George V.
Migausky is an Independent Director at REGENXBIO, Inc. He is on the Board of Directors at REGENXBIO, Inc., Immunovant Sciences Ltd. and Massachusetts Eye & Ear Infirmary, Inc. Mr. Migausky was previously employed as an Independent Director by Abeona Therapeutics, Inc., an Independent Director by Immunovant, Inc., a Chief Financial Officer by Ocular Therapeutix, Inc., an Independent Director by Dimension Therapeutics, Inc., a Chief Financial Officer & Executive Vice President by Dyax Corp., an Independent Director by Hyperion Catalysis International, Inc., a Chief Financial Officer by Wellstat Management Co. LLC, a Chief Financial Officer & Vice President by BioVeris Corp., a Chief Financial Officer & Vice President by IGEN International, Inc., and a Manager by Deloitte & Touche.
He also served on the board at Health Sciences Acquisitions Corp., Immunovant, Inc. /Old/ and Rocket Pharmaceuticals, Inc. He received his undergraduate degree from Boston College and an MBA from Babson College.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
IMMUNOVANT INC 0.07% | 2025-03-31 | 137,251 ( 0.07% ) | 5 M $ | 2026-09-29 |
REGENXBIO, INC. 0.04% | 2026-05-28 | 28,861 ( 0.04% ) | 217 323 $ | 2026-09-29 |
George Migausky active positions
| Companies | Position | Start |
|---|---|---|
| REGENXBIO INC. | Director/Board Member | 2021-09-02 |
Immunovant Sciences Ltd.
 Immunovant Sciences Ltd. BiotechnologyHealth Technology Develops restorative therapies for autoimmune diseases | Director/Board Member | 2020-02-29 |
Massachusetts Eye & Ear Infirmary, Inc.
 Massachusetts Eye & Ear Infirmary, Inc. Medical/Nursing ServicesHealth Services Provides vision and hearing treatments | Director/Board Member | 2014-12-31 |
Former positions of George Migausky
| Companies | Position | End |
|---|---|---|
| IMMUNOVANT, INC. | Director/Board Member | 2025-04-17 |
Hyperion Catalysis International, Inc.
 Hyperion Catalysis International, Inc. Miscellaneous ManufacturingProducer Manufacturing Manufactures plastic tubes | Director/Board Member | 2022-07-31 |
| ABEONA THERAPEUTICS INC. | Director/Board Member | 2020-09-26 |
| DIMENSION THERAPEUTICS INC | Director/Board Member | 2017-11-06 |
| OCULAR THERAPEUTIX, INC. | Director of Finance/CFO | 2017-09-24 |
Education of George Migausky
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
77
1st degree connections
18
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 18 |
|---|---|
Abeona Therapeutics, Inc.
 Abeona Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes cell and gene therapies for life-threatening rare genetic diseases | Health Technology |
Dyax Corp.
 Dyax Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in development and commercialization of novel biotherapeutics | Health Technology |
BioVeris Corp.
 BioVeris Corp. BiotechnologyHealth Technology Develops and manufactures diagnostic products | Health Technology |
Ocular Therapeutix, Inc.
 Ocular Therapeutix, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes therapies for retinal diseases & conditions of the eye | Health Technology |
REGENXBIO, Inc.
 REGENXBIO, Inc. Pharmaceuticals: MajorHealth Technology Develops gene therapy | Health Technology |
IGEN International, Inc.
 IGEN International, Inc. Medical SpecialtiesHealth Technology Develops and markets biological testing systems that incorporate its proprietary electrochemiluminescence technology for used in drug discovery, diagnostic products development as well as food and environmental safety testing | Health Technology |
Babson College
 Babson College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boston College
 Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Deloitte & Touche
 Deloitte & Touche Miscellaneous Commercial ServicesCommercial Services Provides audit, enterprise risk management and financial advisory services | Commercial Services |
Massachusetts Eye & Ear Infirmary, Inc.
Massachusetts Eye & Ear Infirmary, Inc. Medical/Nursing ServicesHealth Services Provides vision and hearing treatments | Health Services |
Wellstat Management Co. LLC
 Wellstat Management Co. LLC Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Commercial Services |
Hyperion Catalysis International, Inc.
Hyperion Catalysis International, Inc. Miscellaneous ManufacturingProducer Manufacturing Manufactures plastic tubes | Producer Manufacturing |
Dimension Therapeutics, Inc.
 Dimension Therapeutics, Inc. BiotechnologyHealth Technology Develops novel treatments for rare diseases | Health Technology |
Rocket Pharmaceuticals, Inc.
 Rocket Pharmaceuticals, Inc. BiotechnologyHealth Technology Provides gene therapy services | Health Technology |
Health Sciences Acquisitions Corp.
 Health Sciences Acquisitions Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Immunovant, Inc. /Old/
 Immunovant, Inc. /Old/ BiotechnologyHealth Technology Develops restorative therapies for autoimmune diseases | Health Technology |
Immunovant Sciences Ltd.
Immunovant Sciences Ltd. BiotechnologyHealth Technology Develops restorative therapies for autoimmune diseases | Health Technology |
Immunovant, Inc.
 Immunovant, Inc. BiotechnologyHealth Technology Develops restorative therapies for autoimmune diseases | Health Technology |
- Stock Market
- Insiders
- George Migausky
